NOD2/CARD15 mutations in Crohn's disease decreases endogenous expression of human alpha 1 defensin (DEFA1) after Salmonella typhimurium infection in colonic epithelial cells

被引:0
|
作者
Yamamoto-Furusho, Jesus K.
Podolsky, Daniel K.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A588 / A588
页数:1
相关论文
共 50 条
  • [41] The Relation Between NOD2/CARD15 Mutations and the Prevalence and Phenotypic Heterogeneity of Crohn’s Disease: Lessons from the Israeli Arab Crohn’s Disease Cohort
    Amir Karban
    Oren Atia
    Eran Leitersdorf
    Azmi Shahbari
    Wisam Sbeit
    Zvi Ackerman
    Rawia Mualem
    Arie Levine
    Shula Nesher
    Rifaat Safadi
    Rami Eliakim
    Digestive Diseases and Sciences, 2005, 50 : 1692 - 1697
  • [42] NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis
    Salkic, Nermin N.
    Adler, Grazyna
    Zawada, Iwona
    Alibegovic, Ervin
    Karakiewicz, Beata
    Kozlowska-Wiechowska, Anna
    Wasilewicz, Michal
    Sulzyc-Bielicka, Violetta
    Bielicki, Dariusz
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2015, 15 (02) : 67 - 72
  • [43] Ileal lymphonular hyperplasia (LNH) and NOD2/CARD15 mutations - the link to Crohn's disease has not been found.
    Shaoul, R
    Eliakim, R
    Karban, A
    GASTROENTEROLOGY, 2005, 128 (04) : A332 - A332
  • [44] Can NOD2/CARD15 mutations predict intestinal graft-versus-host disease and aid our understanding of Crohn's disease?
    Rogler, Gerhard
    Holler, Ernst
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 62 - 63
  • [45] Combined type-1 plasminogen activator inhibitor (PAI-1) and NOD2/CARD15 genotyping predicts Crohn's disease behaviour
    Alvarez-Lobos, M
    Arostegui, JI
    Sans, M
    Tassies, D
    Reverter, JC
    Pique, JM
    Panés, J
    GASTROENTEROLOGY, 2005, 128 (04) : A439 - A439
  • [46] Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour
    Alvarez-Lobos, M.
    Arostegui, J. I.
    Sans, M.
    Tassies, D.
    Piu, J.
    Reverter, J. C.
    Pique, J. . M.
    Yague, J.
    Panes, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (04) : 429 - 440
  • [47] Can NOD2/CARD15 mutations predict intestinal graft-versus-host disease and aid our understanding of Crohn's disease?
    Gerhard Rogler
    Ernst Holler
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 62 - 63
  • [48] NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease
    Molnar, T.
    Hofner, P.
    Nagy, F.
    Lakatos, P. L.
    Fischer, S.
    Lakatos, L.
    Kovacs, A.
    Altorjay, I.
    Papp, M.
    Palatka, K.
    Demeter, P.
    Tulassay, Z.
    Nyari, T.
    Miheller, P.
    Papp, J.
    Mandi, Y.
    Lonovics, J.
    DIGESTIVE AND LIVER DISEASE, 2007, 39 (12) : 1064 - 1070
  • [49] Dmbt1 is a target gene of NOD2/CARD15 and protects intestinal epithelial cells from bacterial invasion
    Rosenstiel, Philip
    Sina, Christian
    Hellmig, Stephan
    Nikolaus, Susanna
    End, Caroline
    Renner, Markus
    Lyer, Stephan
    Helmke, Burkhard
    Hafner, Mathias
    Poustka, Annemarie
    Mollenhauer, Jan
    Schreiber, Stefan
    GASTROENTEROLOGY, 2007, 132 (04) : A550 - A550
  • [50] Polymorphisms in interleukin-10 gene according to mutations of NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn's disease
    JuanLMendoza
    ElenaUrcelay
    RaquelLana
    AlfonsoMartinez
    CarlosTaxonera
    EmilioGdelaConcha
    ManuelDíaz-Rubio
    World Journal of Gastroenterology, 2006, (03) : 443 - 448